Clinical considerations in vaccine trials with special reference to candidate HIV vaccines.
Fast
P E
PE
Vaccine and Prevention Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Sawyer
L A
LA
Wescott
S L
SL
D016915:AIDS Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D017063:Outcome Assessment, Health Care; D012107:Research Design; D014612:Vaccines / Q000009:adverse effects
D016915:AIDS Vaccines; D014612:Vaccines